eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Share:
Send email
Share:
Original paper

A prospective comparison of implant quality between suture-coated seeds and uncoated seeds in prostate cancer brachytherapy

Makoto Nakiri
1
,
Naoyuki Ogasawara
1
,
Hirofumi Kurose
1
,
Kosuke Ueda
1
,
Hiroki Suekane
1
,
Katsuaki Chikui
1
,
Kiyoaki Nishihara
1
,
Keiichiro Uemura
1
,
Kazuhisa Ejima
1
,
Ryuji Hoshino
1
,
Satoshi Onishi
1
,
Keisuke Komiya
1
,
Koichiro Muraki
2
,
Chikayuki Hattori
2
,
Etsuyo Ogo
2
,
Tatsuya Ishitake
3
,
Tsukasa Igawa
1

  1. Department of Urology, Kurume University School of Medicine, Kurume, Japan
  2. Department of Radiology, Kurume University School of Medicine, Kurume, Japan
  3. Department of Environmental Medicine, Kurume University School of Medicine, Kurume, Japan
J Contemp Brachytherapy 2024; 16, 5
DOI: https://doi.org/10.5114/jcb.2024.144175
Online publish date: 2024/10/16
Article file
- A prospective comparison.pdf  [0.30 MB]
Get citation
 
 
1. Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin 2016; 66: 7-30.
2. Bray F, Ferlay J, Soerjomataram I et al. Global cancer statistics: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424.
3. Wilt TJ, Brawer MK, Jones KM et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012; 367: 203-213.
4. Grimm P, Billiet I, Bostwick D et al. Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results of the Prostate Cancer Results Study Group. BJU Int 2012; 109: 22-29.
5. Ito K, Saito S, Yorozu A et al. Nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS): First analysis on survival. Int J Clin Oncol 2018; 23: 1148-1159.
6. Tay KJ, Scheltema MJ, Ahmed HU et al. Patient selection for prostate focal therapy in the era of active surveillance: An International Delphi Consensus Project. Prostate Cancer Prostatic Dis 2017; 20: 294-299.
7. Nakiri M, Ogasawara N, Kurose H et al. Clinical outcomes of iodine-125 low-dose-rate brachytherapy for localized prostate cancer: A single-institution review in Japan. J Contemp Brachytherapy 2022; 14: 157-168.
8. Badwan HO, Shanahan AE, Adams MA et al. Anchorseed for the reduction of source movement in prostate brachytherapy with the Mick applicator implant technique. Brachytherapy 2010; 9: 23-26.
9. Sugawara A, Nakashima J, Kunieda E et al. Incidence of seed migration to the chest, abdomen, and pelvis after transperineal interstitial prostate brachytherapy with loose (125)I seeds. Radiat Oncol 2011; 6: 130.
10. Fuller DB, Koziol JA, Feng AC. Prostate brachytherapy seed migration and dosimetry. Analysis of stranded sources and other potential predictive factors. Brachytherapy 2004; 3: 10-19.
11. Reed DR, Wallner KE, Merrick GS et al. A prospective randomized comparison of stranded vs. Loose 125I seeds for prostate brachytherapy. Brachytherapy 2007; 6: 129-134.
12. Major T, Agoston P, Fröhlich G et al. Loose versus stranded seeds in permanent prostate brachytherapy: Dosimetric comparison of intraoperative plans. Phys Med 2014; 30: 909-913.
13. Daly MB, Pal T, Berry MP et al. Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2021; 19: 77-102.
14. Gregory RW, Yan X, Tarun KP et al. Reduction of seed motion using a bio-absorbable polymer coating during permanent prostate brachytherapy using a mick applicator technique. J Appl Clin Med Phys 2018; 19: 44-51.
15. Basch E, Becker C, Rogak LJ et al. Composite grading algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Clin Trials 2021; 18: 104-114.
16. Kunos CA, Resnick MI, Kinsella TJ et al. Migration of implanted free radioactive seeds for adenocarcinoma of the prostate using a Mick applicator. Brachytherapy 2004; 3: 71-77.
17. Chen WC, Katcher J, Nunez C et al. Radioactive seed migration after transperineal interstitial prostate brachytherapy and associated development of small-cell lung cancer. Brachytherapy 2012; 11: 354-358.
18. Saibishkumar EP, Borg J, Yeung I et al. Loose seeds vs. stranded seeds: A comparison of critical organ dosimetry and acute toxicity in (125)I permanent implant for low-risk prostate cancer. Brachytherapy 2008; 7: 200-205.
19. Abhirup S, Viroon D, Isabella Z et al. Prostate implant dosimetric outcomes and migration patterns between bio-absorbable coated and uncoated brachytherapy seeds. Brachytherapy 2013; 12: 356-361.
20. Marinus AM, Marijke JH, Sjoerd GE et al. Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: Comparison between loose and stranded seed implants. Radiother Oncol 2009; 91: 202-206.
21. Zauls AJ, Ashenafi MS, Onicescu G et al. Comparison of intraoperatively built custom linked seeds versus loose seed gun applicator technique using real-time intraoperative planning for permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2011; 81: 1010-1016.
22. Ishiyama H, Satoh T, Yorozu A et al. Multi-institutional retrospective analysis of learning curves on dosimetry and operation time before and after introduction of intraoperatively built custom-linked seeds in prostate brachytherapy. J Radiat Res 2016; 57: 68-74.
23. Bostwick DG, Waters DJ, Farley ER et al. Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006. Urology 2007; 70: 42-44.
24. Eggener SE, Scardino PT, Carroll PR et al. Focal therapy for localized prostate cancer: A critical appraisal of rationale and modalities. J Urol 2007; 178: 2260-2267.
25. Ahmed HU, Akin O, Coleman JA et al. Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer. BJU Int 2012; 109: 1636-1647.
26. Crawford ED, Barqawi A. Targeted focal therapy: A minimally invasive ablation technique for early prostate cancer. Oncology (Williston Park) 2007; 21: 27-32, 33-34, 39.
27. Muto S, Yoshii T, Saito K et al. Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer. Jpn J Clin Oncol 2008; 38: 192-199.
28. Ahmed HU, Hindley RG, Dickinson L et al. Focal therapy for localised unifocal and multifocal prostate cancer: A prospective development study. Lancet Oncol 2012; 13: 622-632.
29. Onik G, Vaughan D, Lotenfoe R et al. “Male lumpectomy”: Focal therapy for prostate cancer using cryoablation. Urology 2007; 70: 16-21.
30. Shoji S, Nakano M, Fujikawa H et al. Urethra-sparing high-intensity focused ultrasound for localized prostate cancer: Functional and oncological outcomes. Int J Urol 2015; 22: 1043-1049.
31. Nguyen PL, Chen MH, Zhang Y et al. Updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk prostate cancer: Implications for focal therapy. J Urol 2012; 188: 1151-1156.
32. Langley S, Uribe J, Uribe-Lewis S et al. Hemi-ablative low-dose-rate prostate brachytherapy for unilateral localised prostate cancer. BJU Int 2020; 125: 383-390.
33. Andy Y, Tarun P, Jiankui Y et al. Using a deep learning approach for implanted seed detection on fluoroscopy images in prostate brachytherapy. J Contemp Brachytherapy 2023; 15: 69-74.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.